95 results on '"Potvin D"'
Search Results
2. Supplementary Tables from Adaptive significance of affiliative behaviour differs between sexes in a wild reptile population
3. Modelling cave mining in the geotechnical centrifuge
4. 168 Results from APPLAUD phase 2 study with pro-resolution drug candidate LAU-7b in adults with cystic fibrosis
5. Adaptive significance of affiliative behaviour differs between sexes in a wild reptile population.
6. Oral Covid-19 Antiviral Candidate LAU-7b Demonstrates 100% Reduction of the Risk of Progression to Mechanical Ventilation and Death in Hospitalized Moderate-to-Severe Covid-19 Patients
7. Effects of Tesamorelin, a Growth Hormone Releasing Analogue, over 52 Weeks in HIV-Infected Patients with Excess Abdominal Fat: A Pooled Analysis of 2 Multicenter, Randomized, Placebo-Controlled Phase III Trials.
8. Production of recycled manure solids for use as bedding in Canadian dairy farms: II. Composting methods
9. Sitravatinib demonstrates activity in patients with novel genetic alterations that inactivate CBL
10. COMPARISON BETWEEN INDIVIDUAL (IB) AND AVERAGE BIOEQUIVALENCE (AB) FOR 3 HIGHLY VARIABLE DRUGS
11. CHRONIC CNS EXPRESSION OF INTERLEUKIN-6 PRODUCES CHANGES IN EXPRESSION OF STAT3 IN TRANSGENIC MICE.
12. NUCLEAR TRANSLOCATION OF PHOSPHOPROTEINS FOLLOWING BRAIN MICRO TRAUMA.
13. 408O - Sitravatinib demonstrates activity in patients with novel genetic alterations that inactivate CBL
14. Fracture banding in caving mines
15. Field performance of a sliplined watermain
16. Immediate, independent adjustment of call pitch and amplitude in response to varying background noise by silvereyes (Zosterops lateralis)
17. OR2,10 Metabolic effects of tesamorelin, a growth hormone-releasing hormone analogue, in HIV-infected patients with excess abdominal fat: a pooled analysis of 2 multicenter, randomized, placebo-controlled phase 3 trials
18. Prognostic significance of cathepsin-D expression in node-positive breast carcinoma: an immunohistochemical study
19. Stress, song and survival in sparrows
20. Multistage designs for phase II clinical trials: statistical issues in cancer research
21. Aberrations in Plumage Coloration in Birds.
22. High Resolution Spectrum Estimation of FMCW Radar Signals.
23. Nonparametric recovery of duration distrbutions from cross-sectional sample surveys
24. Numerical methods for the evaluation of individual bioequivalence criteria.
25. Predisposing factors related to prosthetic use by people with a transtibial and transfemoral amputation.
26. High Resolution Spectrum Estimation of FMCW Radar Signals
27. Plumage aberrations in Australian birds: A reply to van Grouw (2012).
28. The safety, tolerability and pharmacodynamic responses of interferon BETA-1A (Rebif®) versus interferon BETA-1B (Betaseron®) in healthy male volunteers.
29. Metabolic Effects of a Growth Hormone-Releasing Factor in Patients with HIV.
30. Efficacy and safety of LAU-7b in a Phase 2 trial in adults with cystic fibrosis.
31. Phase II study investigating the efficacy and safety of glesatinib (MGCD265) in patients with advanced NSCLC containing MET activating alterations.
32. Candidate gene polymorphisms are linked to dispersive and migratory behaviour: Searching for a mechanism behind the "paradox of the great speciators".
33. Adaptive significance of affiliative behaviour differs between sexes in a wild reptile population.
34. Mitochondrial Genome Fragmentation Occurred Multiple Times Independently in Bird Lice of the Families Menoponidae and Laemobothriidae.
35. Unexpected Pathogen Diversity Detected in Australian Avifauna Highlights Potential Biosecurity Challenges.
36. Phase I Study Evaluating Glesatinib (MGCD265), An Inhibitor of MET and AXL, in Patients with Non-small Cell Lung Cancer and Other Advanced Solid Tumors.
37. Effect of tesamorelin in people with HIV with and without dorsocervical fat: Post hoc analysis of phase III double-blind placebo-controlled trial.
38. First Randomized, Multicenter, Placebo-Controlled Study of Self-Administered Intranasal Etripamil for Acute Conversion of Spontaneous Paroxysmal Supraventricular Tachycardia (NODE-301).
39. Correction to: Phase I Study of Glesatinib (MGCD265) in Combination with Erlotinib or Docetaxel in Patients with Advanced Solid Tumors.
40. Phase I Study of Glesatinib (MGCD265) in Combination with Erlotinib or Docetaxel in Patients with Advanced Solid Tumors.
41. Characteristics and relationship between hyperphagia, anxiety, behavioral challenges and caregiver burden in Prader-Willi syndrome.
42. Parents report fewer executive functioning problems and repetitive behaviors in young dual-language speakers with autism.
43. Mocetinostat for patients with previously treated, locally advanced/metastatic urothelial carcinoma and inactivating alterations of acetyltransferase genes.
44. Suggestions for Streamlining and Optimizing Clinical End-Point Bioequivalence Studies for US Abbreviated New Drug Application Submissions.
45. Etripamil Nasal Spray for Rapid Conversion of Supraventricular Tachycardia to Sinus Rhythm.
46. Phase I/II study of mocetinostat in combination with gemcitabine for patients with advanced pancreatic cancer and other advanced solid tumors.
47. AZP-531, an unacylated ghrelin analog, improves food-related behavior in patients with Prader-Willi syndrome: A randomized placebo-controlled trial.
48. A phase 2 study of mocetinostat, a histone deacetylase inhibitor, in relapsed or refractory lymphoma.
49. Optimal adaptive sequential designs for crossover bioequivalence studies.
50. Impact of Tesamorelin, a Growth Hormone-Releasing Factor (GRF) Analogue, on the Pharmacokinetics of Simvastatin and Ritonavir in Healthy Volunteers.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.